Real-world safety of apremilast: A pharmacovigilance analysis using the FDA Adverse Event Reporting System (FAERS).

HOME
>
論文・技術情報
>
Real-world safety of apremilast: A pharmacovigilance analysis using the FDA Adverse Event Reporting System (FAERS).

アブストラクト
ジャーナル名	Journal of the American Academy of Dermatology
Pubmed追加日	2025/9/18
投稿者	Chen, Zhi-Yuan; Du, Yang; Guo, Hao
組織名	Department of Dermatology, The First Hospital of China Medical University,;Shenyang, China; Key Laboratory of Immunodermatology, Ministry of Education, and;National Health Commission, National Joint Engineering Research Center for;Theranostics of Immunological Skin Diseases, Shenyang, China.;Theranostics of Immunological Skin Diseases, Shenyang, China. Electronic address:;guohao@cmu.edu.cn.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/40962185/